Molecular pathophysiology of hepatic glucose production

Molecular Aspects of Medicine

Volumn 46, Issue , 2015, Pages 21-33

  Sharabi, Kfir ^a   Tavares, Clint D J ^a   Rines, Amy K ^a   Puigserver, Pere ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

glucagon; gluconeogenesis; glucose; insulin; liver

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; FRUCTOSE 1,6 BISPHOSPHATE; FRUCTOSE 6 PHOSPHATE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOCORTICOID; GLUCOSE; GLUCOSE 6 PHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOENOLPYRUVATE; PYRUVIC ACID; SULFONYLUREA; GLUCOSE BLOOD LEVEL;

ADIPOSE TISSUE; ANTIDIABETIC ACTIVITY; BRAIN; DIET RESTRICTION; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HEPATIC GLUCOSE PRODUCTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN RESISTANCE; INTESTINE; LIVER; LIVER FUNCTION; MOLECULAR PATHOLOGY; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; REFEEDING; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BLOOD; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; GLUCONEOGENESIS; GLUCOSE; HUMANS; HYPERGLYCEMIA; LIVER;

EID: 84948129361     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2015.09.003     Document Type: Review

References (114)

1. D. Accili, and K.C. Arden FoxOs at the crossroads of cellular metabolism, differentiation, and transformation Cell 117 4 2004 421 426
2. G. Ahlborg, L. Hagenfeldt, and J. Wahren Influence of lactate infusion on glucose and FFA metabolism in man Scand. J. Clin. Lab. Invest 36 2 1976 193 201
3. J.Y. Altarejos, and M. Montminy CREB and the CRTC co-activators: sensors for hormonal and metabolic signals Nat. Rev. Mol. Cell Biol 12 3 2011 141 151
4. F.M. Ashcroft, and P. Rorsman Electrophysiology of the pancreatic beta-cell Prog. Biophys. Mol. Biol 54 2 1989 87 143
5. A.D. Baron, G. Brechtel, P. Wallace, and S.V. Edelman Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans Am. J. Physiol 255 6 Pt 1 1988 E769 E774
6. H. Bays, L. Mandarino, and R.A. DeFronzo Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach J. Clin. Endocrinol. Metab 89 2 2004 463 478
7. M.A. Borg, R.S. Sherwin, W.P. Borg, W.V. Tamborlane, and G.I. Shulman Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats J. Clin. Invest 99 2 1997 361 365
8. W.P. Borg, M.J. During, R.S. Sherwin, M.A. Borg, M.L. Brines, and G.I. Shulman Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia J. Clin. Invest 93 4 1994 1677 1682
9. W.P. Borg, R.S. Sherwin, M.J. During, M.A. Borg, and G.I. Shulman Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release Diabetes 44 2 1995 180 184
10. J.P. Boyle, T.J. Thompson, E.W. Gregg, L.E. Barker, and D.F. Williamson Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence Popul. Health Metr 8 2010 29
11. C.F. Burant, and G.I. Bell Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins Biochemistry 31 42 1992 10414 10420
12. P.J. Campbell, L.J. Mandarino, and J.E. Gerich Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus Metabolism 37 1 1988 15 21
13. Chen L., D.J. Magliano, and P.Z. Zimmet The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives Nat. Rev. Endocrinol 8 4 2012 228 236
14. A.D. Cherrington Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo Diabetes 48 5 1999 1198 1214
15. M.G. Clark, N.M. Kneer, A.L. Bosch, and H.A. Lardy The fructose 1,6-diphosphatase-phosphofructokinase substrate cycle. A site of regulation of hepatic gluconeogenesis by glucagon J. Biol. Chem 249 18 1974 5695 5703
16. T.H. Claus, J.R. Schlumpf, M.R. el-Maghrabi, J. Pilkis, and S.J. Pilkis Mechanism of action of glucagon on hepatocyte phosphofructokinase activity Proc. Natl. Acad. Sci. U.S.A. 77 11 1980 6501 6505
17. A. Consoli, N. Nurjhan, F. Capani, and J. Gerich Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM Diabetes 38 5 1989 550 557
18. H. Daitoku, M. Hatta, H. Matsuzaki, S. Aratani, T. Ohshima, M. Miyagishi, and et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity Proc. Natl. Acad. Sci. U.S.A. 101 27 2004 10042 10047
19. C.F. Deacon Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review Diabetes Obes. Metab 13 1 2011 7 18
20. R.A. DeFronzo Pathogenesis of type 2 diabetes mellitus Med. Clin. North Am 88 4 2004 787 835 ix
21. R.A. DeFronzo, D. Simonson, and E. Ferrannini Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus Diabetologia 23 4 1982 313 319
22. R.A. DeFronzo, R. Gunnarsson, O. Bjorkman, M. Olsson, and J. Wahren Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus J. Clin. Invest 76 1 1985 149 155
23. M.P. Diamond, R.C. Rollings, K.E. Steiner, P.E. Williams, W.W. Lacy, and A.D. Cherrington Effect of alanine concentration independent of changes in insulin and glucagon on alanine and glucose homeostasis in the conscious dog Metabolism 37 1 1988 28 33
24. J.E. Dominy Jr., Y. Lee, M.P. Jedrychowski, H. Chim, M.J. Jurczak, J.P. Camporez, and et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis Mol. Cell 48 6 2012 900 913
25. D.J. Drucker Glucagon-like peptides Diabetes 47 2 1998 159 169
26. M.Y. El-Mir, V. Nogueira, E. Fontaine, N. Averet, M. Rigoulet, and X. Leverve Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I J. Biol. Chem 275 1 2000 223 228
27. L. Engstrom The regulation of liver pyruvate kinase by phosphorylation-dephosphorylation Curr. Top. Cell. Regul 13 1978 28 51
28. J.H. Exton, and C.R. Park Control of gluconeogenesis in liver. I. General features of gluconeogenesis in the perfused livers of rats J. Biol. Chem 242 11 1967 2622 2636
29. J.E. Feliu, L. Hue, and H.G. Hers Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes Proc. Natl. Acad. Sci. U.S.A. 73 8 1976 2762 2766
30. R.G. Firth, P.M. Bell, H.M. Marsh, I. Hansen, and R.A. Rizza Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues J. Clin. Invest 77 5 1986 1525 1532
31. W. Flory, B.D. Peczon, R.E. Koeppe, and H.O. Spivey Kinetic properties of rat liver pyruvate kinase at cellular concentrations of enzyme, substrates and modifiers Biochem. J. 141 1 1974 127 131
32. M. Foretz, S. Hébrard, J. Leclerc, E. Zarrinpashneh, M. Soty, G. Mithieux, and et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state J. Clin. Invest 120 7 2010 2355 2369
33. J.C. Garrison, and J.D. Wagner Glucagon and the Ca2+-linked hormones angiotensin II, norepinephrine, and vasopressin stimulate the phosphorylation of distinct substrates in intact hepatocytes J. Biol. Chem 257 21 1982 13135 13143
34. A. Gastaldelli, E. Toschi, M. Pettiti, S. Frascerra, A. Quiñones-Galvan, A.M. Sironi, and et al. Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients Diabetes 50 8 2001 1807 1812
35. R.W. Gelling, G.J. Morton, C.D. Morrison, K.D. Niswender, M.G. Myers Jr., C.J. Rhodes, and et al. Insulin action in the brain contributes to glucose lowering during insulin treatment of diabetes Cell Metab 3 1 2006 67 73
36. J.E. Gerich Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications Diabet. Med 27 2 2010 136 142
37. J.E. Gerich, A. Mitrakou, D. Kelley, L. Mandarino, N. Nurjhan, J. Reilly, and et al. Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM Diabetes 39 2 1990 211 216
38. F.M. Gribble, S.J. Tucker, S. Seino, and F.M. Ashcroft Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels Diabetes 47 9 1998 1412 1418
39. L.C. Groop, R.C. Bonadonna, S. DelPrato, K. Ratheiser, K. Zyck, E. Ferrannini, and et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance J. Clin. Invest 84 1 1989 205 213
40. R.A. Haeusler, K.H. Kaestner, and D. Accili FoxOs function synergistically to promote glucose production J. Biol. Chem 285 46 2010 35245 35248
41. P.O. Hasselgren Glucocorticoids and muscle catabolism Curr. Opin. Clin. Nutr. Metab. Care 2 3 1999 201 205
42. He L., and F.E. Wondisford Metformin action: concentrations matter Cell Metab 21 2 2015 159 162
43. S. Herzig, Long F., U.S. Jhala, S. Hedrick, R. Quinn, A. Bauer, and et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 Nature 413 6852 2001 179 183
44. J.J. Holst The physiology of glucagon-like peptide 1 Physiol. Rev 87 4 2007 1409 1439
45. Huang S.C., M.E. Phelps, E.J. Hoffman, K. Sideris, C.J. Selin, and D.E. Kuhl Noninvasive determination of local cerebral metabolic rate of glucose in man Am. J. Physiol 238 1 1980 E69 E82
46. S.E. Inzucchi, R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, M. Nauck, and et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 55 6 2012 1577 1596
47. P.B. Iynedjian Molecular physiology of mammalian glucokinase Cell. Mol. Life Sci 66 1 2009 27 42
48. F. Jahoor, E.J. Peters, and R.R. Wolfe The relationship between gluconeogenic substrate supply and glucose production in humans Am. J. Physiol 258 2 Pt 1 1990 E288 E296
49. T. Jenssen, N. Nurjhan, A. Consoli, and J.E. Gerich Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration J. Clin. Invest 86 2 1990 489 497
50. A.M. Johnson, and J.M. Olefsky The origins and drivers of insulin resistance Cell 152 4 2013 673 684
51. D. Knutti, A. Kaul, and A. Kralli A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen Mol. Cell. Biol 20 7 2000 2411 2422
52. S.H. Koo, L. Flechner, Qi L., Zhang X., R.A. Screaton, S. Jeffries, and et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism Nature 437 7062 2005 1109 1111
53. L. Koranyi, D. James, M. Mueckler, and M.A. Permutt Glucose transporter levels in spontaneously obese (db/db) insulin-resistant mice J. Clin. Invest 85 3 1990 962 967
54. T.K. Lam, R. Gutierrez-Juarez, A. Pocai, and L. Rossetti Regulation of blood glucose by hypothalamic pyruvate metabolism Science 309 5736 2005 943 947
55. C. Lambillotte, P. Gilon, and J.C. Henquin Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets J. Clin. Invest 99 3 1997 414 423
56. N. Lanthier, O. Molendi-Coste, Y. Horsmans, N. van Rooijen, P.D. Cani, and I.A. Leclercq Kupffer cell activation is a causal factor for hepatic insulin resistance Am. J. Physiol. Gastrointest. Liver Physiol 298 1 2010 G107 G116
57. Y. Lee, J.E. Dominy, Y.J. Choi, M. Jurczak, N. Tolliday, J.P. Camporez, and et al. Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression Nature 510 7506 2014 547 551
58. C. Lerin, J.T. Rodgers, D.E. Kalume, S.H. Kim, A. Pandey, and P. Puigserver GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha Cell Metab 3 6 2006 429 438
59. G.F. Lewis, M. Vranic, P. Harley, and A. Giacca Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans Diabetes 46 7 1997 1111 1119
60. Liang Y., M.C. Osborne, B.P. Monia, S. Bhanot, W.A. Gaarde, C. Reed, and et al. Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice Diabetes 53 2 2004 410 417
61. Lin H.V., and D. Accili Hormonal regulation of hepatic glucose production in health and disease Cell Metab 14 1 2011 9 19
62. Lu M., Wan M., K.F. Leavens, Chu Q., B.R. Monks, S. Fernandez, and et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1 Nat. Med 18 3 2012 388 395
63. C.N. Lumeng, and A.R. Saltiel Inflammatory links between obesity and metabolic disease J. Clin. Invest 121 6 2011 2111 2117
64. Y. Lustig, J.L. Ruas, J.L. Estall, J.C. Lo, S. Devarakonda, D. Laznik, and et al. Separation of the gluconeogenic and mitochondrial functions of PGC-1{alpha} through S6 kinase Genes Dev 25 12 2011 1232 1244
65. A.K. Madiraju, D.M. Erion, Y. Rahimi, Zhang X.M., D.T. Braddock, R.A. Albright, and et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase Nature 510 7506 2014 542 546
66. I. Magnusson, D.L. Rothman, L.D. Katz, R.G. Shulman, and G.I. Shulman Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study J. Clin. Invest 90 4 1992 1323 1327
67. M. Martin, and R. Marais Metformin: a diabetes drug for cancer, or a cancer drug for diabetics? J. Clin. Oncol 30 21 2012 2698 2700
68. F.M. Matschinsky Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm Diabetes 45 2 1996 223 241
69. M. Matsumoto, A. Pocai, L. Rossetti, R.A. Depinho, and D. Accili Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver Cell Metab 6 3 2007 208 216
70. H. Matsuzaki, H. Daitoku, M. Hatta, H. Aoyama, K. Yoshimochi, and A. Fukamizu Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation Proc. Natl. Acad. Sci. U.S.A. 102 32 2005 11278 11283
71. D.W. Meek, and H.G. Nimmo Effects of phosphorylation on the kinetic properties of rat liver fructose-1,6-bisphosphatase Biochem. J. 222 1 1984 125 130
72. M.D. Michael, R.N. Kulkarni, C. Postic, S.F. Previs, G.I. Shulman, M.A. Magnuson, and et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction Mol. Cell 6 1 2000 87 97
73. R.A. Miller, Chu Q., Xie J., M. Foretz, B. Viollet, and M.J. Birnbaum Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP Nature 494 7436 2013 256 260
74. A. Mitrakou, C. Ryan, T. Veneman, M. Mokan, T. Jenssen, I. Kiss, and et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction Am. J. Physiol 260 1 Pt 1 1991 E67 E74
75. M.C. Moore, K.C. Coate, J.J. Winnick, An Z., and A.D. Cherrington Regulation of hepatic glucose uptake and storage in vivo Adv. Nutr 3 3 2012 286 294
76. E. Mutel, A. Gautier-Stein, A. Abdul-Wahed, M. Amigo-Correig, C. Zitoun, A. Stefanutti, and et al. Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon Diabetes 60 12 2011 3121 3131
77. A.M. Neyrinck, P.D. Cani, E.M. Dewulf, F. De Backer, L.B. Bindels, and N.M. Delzenne Critical role of Kupffer cells in the management of diet-induced diabetes and obesity Biochem. Biophys. Res. Commun 385 3 2009 351 356
78. S. Obici, Zhang B.B., G. Karkanias, and L. Rossetti Hypothalamic insulin signaling is required for inhibition of glucose production Nat. Med 8 12 2002 1376 1382
79. A.E. Obstfeld, E. Sugaru, M. Thearle, A.M. Francisco, C. Gayet, H.N. Ginsberg, and et al. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis Diabetes 59 4 2010 916 925
80. C. Opherk, F. Tronche, C. Kellendonk, D. Kohlmuller, A. Schulze, W. Schmid, and et al. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus Mol. Endocrinol 18 6 2004 1346 1353
81. M.R. Owen, E. Doran, and A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem. J. 348 Pt 3 2000 607 614
82. A.J. Peckett, D.C. Wright, and M.C. Riddell The effects of glucocorticoids on adipose tissue lipid metabolism Metabolism 60 11 2011 1500 1510
83. S.J. Pilkis, and D.K. Granner Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis Annu. Rev. Physiol 54 1992 885 909
84. S.J. Pilkis, T.D. Chrisman, M.R. El-Maghrabi, A. Colosia, E. Fox, J. Pilkis, and et al. The action of insulin on hepatic fructose 2,6-bisphosphate metabolism J. Biol. Chem 258 3 1983 1495 1503
85. S.J. Pilkis, T.H. Claus, I.J. Kurland, and A.J. Lange 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzyme Annu. Rev. Biochem 64 1995 799 835
86. P. Proks, F. Reimann, N. Green, F. Gribble, and F. Ashcroft Sulfonylurea Stimulation of Insulin Secretion Diabetes 51 Suppl. 3 2002 S368 S376
87. P. Puigserver, Wu Z., C.W. Park, R. Graves, M. Wright, and B.M. Spiegelman A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis Cell 92 6 1998 829 839
88. P. Puigserver, J. Rhee, J. Donovan, C.J. Walkey, J.C. Yoon, F. Oriente, and et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction Nature 423 6939 2003 550 555
89. I. Quesada, E. Tudurí, C. Ripoll, and Á. Nadal Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes J. Endocrinol 199 1 2008 5 19
90. P.G. Quinn, and D.K. Granner Cyclic AMP-dependent protein kinase regulates transcription of the phosphoenolpyruvate carboxykinase gene but not binding of nuclear factors to the cyclic AMP regulatory element Mol. Cell. Biol 10 7 1990 3357 3364
91. B. Raju, and P.E. Cryer Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon? Am. J. Physiol. Endocrinol. Metab 289 2 2005 E181 E186
92. K. Rebrin, G.M. Steil, L. Getty, and R.N. Bergman Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin Diabetes 44 9 1995 1038 1045
93. J. Rhee, Y. Inoue, J.C. Yoon, P. Puigserver, Fan M., F.J. Gonzalez, and et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis Proc. Natl. Acad. Sci. U.S.A. 100 7 2003 4012 4017
94. R.A. Rizza Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy Diabetes 59 11 2010 2697 2707
95. R.A. Rizza, P.E. Cryer, M.W. Haymond, and J.E. Gerich Adrenergic mechanisms of catecholamine action on glucose homeostasis in man Metabolism 29 11 Suppl. 1 1980 1155 1163
96. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, and P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 7029 2005 113 118
97. J.T. Rodgers, W. Haas, S.P. Gygi, and P. Puigserver Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis Cell Metab 11 1 2010 23 34
98. V.H. Routh, Kang L., N.M. Sanders, and A.A. Dunn-Meynell Neuronal glucosensing what do we know after 50 years? Diabetes 53 10 2004 2521 2528
99. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 6865 2001 799 806
100. V.T. Samuel, and G.I. Shulman Mechanisms for insulin resistance: common threads and missing links Cell 148 5 2012 852 871
101. R.A. Screaton, M.D. Conkright, Y. Katoh, J.L. Best, G. Canettieri, S. Jeffries, and et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector Cell 119 1 2004 61 74
102. R.J. Shaw, K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, R.A. Depinho, and et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science 310 5754 2005 1642 1646
103. She P., M. Shiota, K.D. Shelton, R. Chalkley, C. Postic, and M.A. Magnuson Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism Mol. Cell. Biol 20 17 2000 6508 6517
104. She P., S.C. Burgess, M. Shiota, P. Flakoll, E.P. Donahue, C.R. Malloy, and et al. Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation Diabetes 52 7 2003 1649 1654
105. D.K. Sindelar, Chu C.A., M. Rohlie, D.W. Neal, L.L. Swift, and A.D. Cherrington The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog Diabetes 46 2 1997 187 196
106. R.H. Unger, E. Aguilar-Parada, W.A. Muller, and A.M. Eisentraut Studies of pancreatic alpha cell function in normal and diabetic subjects J. Clin. Invest 49 4 1970 837 848
107. P.D. van Poelje, S.C. Potter, and M.D. Erion Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes Handb. Exp. Pharmacol 203 2011 279 301
108. E. Van Schaftingen Fructose 2,6-bisphosphate Adv. Enzymol. Relat. Areas Mol. Biol 59 1987 315 395
109. E. Van Schaftingen, L. Hue, and H.G. Hers Control of the fructose-6-phosphate/fructose 1,6-bisphosphate cycle in isolated hepatocytes by glucose and glucagon. Role of a low-molecular-weight stimulator of phosphofructokinase Biochem. J. 192 3 1980 887 895
110. E. Van Schaftingen, L. Hue, and H.G. Hers Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase Biochem. J. 192 3 1980 897 901
111. L.M. Watts, V.P. Manchem, T.A. Leedom, A.L. Rivard, R.A. McKay, Bao D., and et al. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism Diabetes 54 6 2005 1846 1853
112. A. Wynshaw-Boris, J.M. Short, D.S. Loose, and R.W. Hanson Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. I. Multiple hormone regulatory elements and the effects of enhancers J. Biol. Chem 261 21 1986 9714 9720
113. J.C. Yoon, P. Puigserver, Chen G., J. Donovan, Wu Z., J. Rhee, and et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 Nature 413 6852 2001 131 138
114. Zhou G., R. Myers, Li Y., Chen Y., Shen X., J. Fenyk-Melody, and et al. Role of AMP-activated protein kinase in mechanism of metformin action J. Clin. Invest 108 8 2001 1167 1174